These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 25562645)
1. Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy. Plückthun A Annu Rev Pharmacol Toxicol; 2015; 55():489-511. PubMed ID: 25562645 [TBL] [Abstract][Full Text] [Related]
2. Advances in the Application of Designed Ankyrin Repeat Proteins (DARPins) as Research Tools and Protein Therapeutics. Boersma YL Methods Mol Biol; 2018; 1798():307-327. PubMed ID: 29868969 [TBL] [Abstract][Full Text] [Related]
3. Designed ankyrin repeat proteins (DARPins) from research to therapy. Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567 [TBL] [Abstract][Full Text] [Related]
4. DARPin-Based Crystallization Chaperones Exploit Molecular Geometry as a Screening Dimension in Protein Crystallography. Batyuk A; Wu Y; Honegger A; Heberling MM; Plückthun A J Mol Biol; 2016 Apr; 428(8):1574-88. PubMed ID: 26975886 [TBL] [Abstract][Full Text] [Related]
5. From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display. Schilling J; Schöppe J; Plückthun A J Mol Biol; 2014 Feb; 426(3):691-721. PubMed ID: 24513107 [TBL] [Abstract][Full Text] [Related]
6. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases. Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706 [TBL] [Abstract][Full Text] [Related]
7. DARPins: a true alternative to antibodies. Stumpp MT; Amstutz P Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550 [TBL] [Abstract][Full Text] [Related]
8. Designed Ankyrin Repeat Proteins: A Look at their Evolving Use in Medicine with a Focus on the Treatment of Chorioretinal Vascular Disorders. Smithwick E; Stewart MW Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):33-45. PubMed ID: 28464780 [TBL] [Abstract][Full Text] [Related]
9. Structural determinants for improved stability of designed ankyrin repeat proteins with a redesigned C-capping module. Kramer MA; Wetzel SK; Plückthun A; Mittl PR; Grütter MG J Mol Biol; 2010 Dec; 404(3):381-91. PubMed ID: 20851127 [TBL] [Abstract][Full Text] [Related]
10. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size. Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480 [TBL] [Abstract][Full Text] [Related]
11. DARPins: a new generation of protein therapeutics. Stumpp MT; Binz HK; Amstutz P Drug Discov Today; 2008 Aug; 13(15-16):695-701. PubMed ID: 18621567 [TBL] [Abstract][Full Text] [Related]
12. Knowledge-based design of reagentless fluorescent biosensors from a designed ankyrin repeat protein. Brient-Litzler E; Plückthun A; Bedouelle H Protein Eng Des Sel; 2010 Apr; 23(4):229-41. PubMed ID: 19945965 [TBL] [Abstract][Full Text] [Related]
13. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. Steiner D; Forrer P; Plückthun A J Mol Biol; 2008 Oct; 382(5):1211-27. PubMed ID: 18706916 [TBL] [Abstract][Full Text] [Related]
14. Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters. Dreier B; Honegger A; Hess C; Nagy-Davidescu G; Mittl PR; Grütter MG; Belousova N; Mikheeva G; Krasnykh V; Plückthun A Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E869-77. PubMed ID: 23431166 [TBL] [Abstract][Full Text] [Related]
15. A designed ankyrin repeat protein evolved to picomolar affinity to Her2. Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328 [TBL] [Abstract][Full Text] [Related]
16. Designed ankyrin repeat proteins as anti-idiotypic-binding molecules. Vogel M; Keller-Gautschi E; Baumann MJ; Amstutz P; Ruf C; Kricek F; Stadler BM Ann N Y Acad Sci; 2007 Aug; 1109():9-18. PubMed ID: 17785285 [TBL] [Abstract][Full Text] [Related]
17. Chaperone-assisted structure elucidation with DARPins. Mittl PR; Ernst P; Plückthun A Curr Opin Struct Biol; 2020 Feb; 60():93-100. PubMed ID: 31918361 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure and function of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode. Veesler D; Dreier B; Blangy S; Lichière J; Tremblay D; Moineau S; Spinelli S; Tegoni M; Plückthun A; Campanacci V; Cambillau C J Biol Chem; 2009 Oct; 284(44):30718-26. PubMed ID: 19740746 [TBL] [Abstract][Full Text] [Related]
19. Structural Basis for the Selective Inhibition of c-Jun N-Terminal Kinase 1 Determined by Rigid DARPin-DARPin Fusions. Wu Y; Honegger A; Batyuk A; Mittl PRE; Plückthun A J Mol Biol; 2018 Jul; 430(14):2128-2138. PubMed ID: 29126898 [TBL] [Abstract][Full Text] [Related]
20. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries. Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]